Losing NIH funding, according to Dr. Lipton, would stop the research done at Michigan State University's College of Human ...
2h
AZoLifeSciences on MSNNovel Antibody Platform Targets Aggregates in Alzheimer's and Parkinson'sIn diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...
Cleveland Clinic researchers are using artificial intelligence to identify existing FDA-approved drugs that may be repurposed to treat other complex diseases. The effort is led by Feixiong Cheng, PhD, ...
The factor that tips you over the edge from being at risk for a disease to actually developing the disease is not always ...
A new discovery from an international collaborative research team has solved the mystery of how cells turn on their recycling ...
15h
GlobalData on MSNAlzeCure Pharma secures €2.5m grant for Phase IIa trial of Alzheimer’s treatmentThe trial will explore the effects of higher doses of ACD856, building on the drug’s established safety profile.
Glaucoma is a group of eye diseases that damage the optic nerve, which connects the eye to the brain. In most cases, glaucoma is caused by high pressure inside the eye. However, normal-tension ...
Researchers from Osaka University find that peristaltic pump action and high shear flow forces promote amyloid nucleation.
Researchers from Osaka University found that peristaltic pump flow mechanically breaks supersaturation to induce amyloid ...
Research finds that 40 percent of dementia cases may be preventable—and healthy diets rich in polyphenols, healthy fats, and whole foods play a key role.
In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...
In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results